A couple of media reports have suggested that the company’s promoters have initiated a formal process to sell their stake and have roped in investment banking firm Barclays to handle the process.
“The company, its promoters and management team are committed to operating Metropolis Healthcare Limited with the highest standards of medical science, stakeholder trust and customer engagement. Promoters have no intention to exit the business and are in fact focused on strengthening the Metropolis Brand,” the company clarified on the BSE.
“Any step taken by the Promoters and Management Team will be in the view of long-term growth prospects of the company and in the best interest of all stakeholders,” it added.